SVRA - Savara Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.57 0.33 (7.22%) 0.0 (0.0%) 0.0 (-0.1%) 0.06 (1.14%) 0.08 (1.75%) 0.24 (5.15%) --- 0.08 (1.75%)

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.12
Diluted EPS:
-0.12
Basic P/E:
-40.8333
Diluted P/E:
-40.8333
RSI(14) 1m:
71.43
VWAP:
4.9
RVol:

Events

Period Kind Movement Occurred At

Related News